Literature DB >> 448149

Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells.

S Kohl, D L Cahall, D L Walters, V E Schaffner.   

Abstract

Freshly collected peritoneal cells (PC) and cultured spleen cells (SC) (but not fresh SC) from nonimmune mice could mediate antibody-dependent cellular cytotoxicity (ADCC) against herpes simplex virus (HSV)-infected cells in the presence of mouse or human sera containing antibody to HSV. PC also demonstrated variable natural killer cell cytotoxicity to infected cells. Both PC and cultured SC required high concentrations of antibody and high effector to target cell ratios for optimal ADCC. The time kinetics of the reaction appeared to depend on the state of activation of the effector cells. In both PC and SC populations, ADCC activity was limited to adherent cells, and was profoundly inhibited by particulate latex or silica. The murine effector cell found in PC and SC able to mediate ADCC to HSV-infected cells appears to be a macrophage.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448149

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia.

Authors:  J E Oakes; R N Lausch
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

2.  Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.

Authors:  Adalbert Krawczyk; Jürgen Krauss; Anna M Eis-Hübinger; Martin P Däumer; Robert Schwarzenbacher; Ulf Dittmer; Karl E Schneweis; Dirk Jäger; Michael Roggendorf; Michaela A E Arndt
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  Antivirus antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.

Authors:  J E Manischewitz; G V Quinnan
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

4.  Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation.

Authors:  M C Rattray; G M Peterman; L C Altman; L Corey; K K Holmes
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

5.  Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.

Authors:  N Balachandran; S Bacchetti; W E Rawls
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

6.  Cytotoxicity of human peripheral blood and colostral leukocytes against Shigella species.

Authors:  D R Morgan; H L DuPont; B Gonik; S Kohl
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.

Authors:  S Kohl; D B Drath; L S Loo
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.

Authors:  J T Rector; R N Lausch; J E Oakes
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity.

Authors:  G Dubin; E Socolof; I Frank; H M Friedman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Activity of rabbit monocytes, macrophages, and neutrophils in antibody-dependent cellular cytotoxicity of herpes simplex virus-infected corneal cells.

Authors:  J W Smith; A M Sheppard
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.